about
Screening of a chemical library reveals novel PXR-activating pharmacologic compounds.Sugar-Modified Poly(propylene imine) Dendrimers Stimulate the NF-κB Pathway in a Myeloid Cell Line.Dendrimers as nanocarriers for nucleoside analogues.Pyrrolidone Modification Prevents PAMAM Dendrimers from Activation of Pro-Inflammatory Signaling Pathways in Human Monocytes.Glycodendrimer Nanocarriers for Direct Delivery of Fludarabine Triphosphate to Leukemic Cells: Improved Pharmacokinetics and Pharmacodynamics of Fludarabine.Poly(propyleneimine) glycodendrimers non-covalently bind ATP in a pH- and salt-dependent manner – model studies for adenosine analogue drug deliveryComplexes of Indomethacin with 4-Carbomethoxy-pyrrolidone PAMAM Dendrimers Show Improved Anti-inflammatory Properties and Temperature-Dependent Binding and Release ProfileTerminal Sugar Moiety Determines Immunomodulatory Properties of Poly(propyleneimine) GlycodendrimersFludarabine-Specific Molecular Interactions with Maltose-Modified Poly(propyleneimine) Dendrimer Enable Effective Cell Entry of the Active Drug Form: Comparison with ClofarabineEffect of the Structure of Therapeutic Adenosine Analogues on Stability and Surface Electrostatic Potential of their Complexes with Poly(propyleneimine) DendrimersNanocarriers in photodynamic therapy-in vitro and in vivo studiesSugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells - Possible Role of GLUT1 TransporterPyrrolidone-modified PAMAM dendrimers enhance anti-inflammatory potential of indomethacin in vitroGold Nanoparticles in Cancer TreatmentPoly(lysine) Dendrimers Form Complexes with siRNA and Provide Its Efficient Uptake by Myeloid Cells: Model Studies for Therapeutic Nucleic Acid Delivery
P50
Q35470873-FD718070-B39E-4982-AFC0-833EECF2D94FQ37521447-F9CD214B-8F86-4EBF-B022-04B02E77189AQ39019403-2b5ae057-4a8f-bd32-da9d-6f963675c23aQ47346054-2a567ce5-495b-911d-81bf-9c7bc4a3f439Q48261265-27e3e61e-46f3-a84c-147b-c8983ad9c02fQ57362905-7045ee9d-448c-3786-4253-e40e82461238Q59921860-CD01ABE7-C401-4C37-ABDB-A450BEA2BD25Q59921911-f602a6bb-44f6-3b4c-5949-22a3bd0ca92fQ62491064-4FE6B2A2-CBE4-45F8-AFB0-4958A47E9E5FQ66475721-13f3313d-49f3-5259-73c7-158bea66be1cQ91138053-F70451B1-337A-48E6-8BB1-23DF8D6D1F38Q92328419-3D94B025-9154-4E5A-8C29-94E9AFF3509FQ92420765-84CC3295-7F0E-4748-818F-EF946EEAA533Q93212553-FE96DFED-CB6D-4C04-BDB4-EE3FDB461A51Q94514421-A270BB7C-A13A-4A68-B89B-5CF8D27BCB0C
P50
description
researcher ORCID ID = 0000-0001-9258-3626
@en
wetenschapper
@nl
name
Michal Gorzkiewicz
@ast
Michal Gorzkiewicz
@en
Michal Gorzkiewicz
@es
Michal Gorzkiewicz
@nl
type
label
Michal Gorzkiewicz
@ast
Michal Gorzkiewicz
@en
Michal Gorzkiewicz
@es
Michal Gorzkiewicz
@nl
prefLabel
Michal Gorzkiewicz
@ast
Michal Gorzkiewicz
@en
Michal Gorzkiewicz
@es
Michal Gorzkiewicz
@nl
P106
P1153
56420005500
P21
P31
P496
0000-0001-9258-3626